Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Equity Average (2016 - 2025)

Historic Equity Average for Pediatrix Medical (MD) over the last 16 years, with Q3 2025 value amounting to $862.2 million.

  • Pediatrix Medical's Equity Average rose 1983.85% to $862.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $862.2 million, marking a year-over-year increase of 1983.85%. This contributed to the annual value of $807.0 million for FY2024, which is 727.84% down from last year.
  • Pediatrix Medical's Equity Average amounted to $862.2 million in Q3 2025, which was up 1983.85% from $811.5 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Equity Average peaked at $955.2 million during Q3 2023, and registered a low of $719.5 million during Q3 2024.
  • Its 5-year average for Equity Average is $840.1 million, with a median of $852.6 million in 2024.
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 4927.99% in 2021, then soared by 1983.85% in 2025.
  • Over the past 5 years, Pediatrix Medical's Equity Average (Quarter) stood at $871.2 million in 2021, then increased by 0.46% to $875.1 million in 2022, then grew by 3.81% to $908.5 million in 2023, then dropped by 17.59% to $748.7 million in 2024, then increased by 15.16% to $862.2 million in 2025.
  • Its Equity Average stands at $862.2 million for Q3 2025, versus $811.5 million for Q2 2025 and $777.1 million for Q1 2025.